Results 251 to 260 of about 143,284 (315)
Multi-omics investigation of perineural invasion in head and neck squamous cell carcinoma: neuroimmune mechanisms and clinical implications. [PDF]
Deng M +5 more
europepmc +1 more source
ABSTRACT Objective Chronic otitis media (COM) is a major public health concern, particularly in developing countries. Although complications have decreased with modern antibiotics, they still cause significant morbidity and mortality. This study analyzed the clinical features, bacteriological profiles, and treatment outcomes of COM complications at a ...
Viraporn Atchariyasathian +1 more
wiley +1 more source
Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma. [PDF]
Wang Z +14 more
europepmc +1 more source
ABSTRACT Background Sinonasal malignancies with orbital involvement may be managed with orbit‐sacrificing or orbit‐preserving surgical approaches, with a recent shift towards orbital preservation to reduce postoperative morbidity while maintaining oncological success.
Claire Jing‐Wen Tan +9 more
wiley +1 more source
STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma. [PDF]
MacNeil T +12 more
europepmc +1 more source
ABSTRACT Objectives Treatment landscapes are changing for HPV+ oropharyngeal cancer (OPC) without compromising oncologic outcomes. We aim to analyze treatment trends of HPV+ OPC at academic (ACs) and nonacademic centers (NACs). Methods The National Cancer Database was queried, and multinomial logistic regression was used to predict treatment trends ...
Monica S. Trent +4 more
wiley +1 more source
Platycodin D sensitizes head and neck squamous cell carcinoma to cisplatin by inducing autophagy arrest. [PDF]
Bae M +9 more
europepmc +1 more source
ABSTRACT Objective Currently, there are no blood biomarkers available for the early diagnosis of laryngeal squamous cell carcinoma (LSCC). The objective of this study was to search for potential plasma biomarkers for the diagnosis of LSCC. Methods Plasma samples were taken from patients with LSCC and healthy controls for proteomic analysis.
Shuang Teng +13 more
wiley +1 more source
Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinoma. [PDF]
Colevas AD +19 more
europepmc +1 more source

